Minneapolis-based Vital Images has recruited eight accredited institutional investors to purchase 1.5 million shares of common stock at $13.50 per share. The private placement, announced June 2, generated some $19 million after deducting closing costs
Minneapolis-based Vital Images has recruited eight accredited institutional investors to purchase 1.5 million shares of common stock at $13.50 per share. The private placement, announced June 2, generated some $19 million after deducting closing costs and placement fees. U.S. Bancorp Piper Jaffray served as exclusive placement agent for the transaction. Funds will provide the flexibility to expand VI's business through acquisition or other opportunities, according to the company. In weeks prior to the placement, VI stock soared to nearly $18. As of June 5, share price had settled at about $14.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.